GlucoTrack, Inc. GCTK
Set alert
As of Nov 2, 3:47 PM ET
- YTD
- -99.58%
- 1 year
- -99.75%
- Open
- 0.76
- Prev close
- 0.80
- Mkt cap
- 580.22K
- Vol
- 73.95K
- Avg vol
- 1.90M
- EPS
- -246.30
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.49
- High
- 0.7604
- Forward P/E
- 0.00
- Beta
- 0.16
- Short ratio
- 6.03
- Inst. own
- 0.95%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.97332
- 200-d avg
- 1.89
- 1y target
- 0.00
5D chart
Signals (73)
| Name | Time | Ago |
|---|---|---|
| RSI: Oversold | Nov 2, 3:25 PM | 6 hours ago |
| RSI: Oversold | Nov 2, 2:55 PM | 7 hours ago |
| SMA: Bearish | Nov 2, 12:45 PM | 9 hours ago |
| SMA: Bullish | Nov 2, 12:25 PM | 9 hours ago |
| RSI: Oversold | Nov 2, 12:20 PM | 9 hours ago |
| SMA: Bearish | Nov 2, 12:10 PM | 9 hours ago |
| SMA: Bullish | Nov 2, 11:40 AM | 10 hours ago |
| SMA: Bearish | Nov 2, 11:05 AM | 11 hours ago |
| SMA: Bullish | Nov 2, 10:55 AM | 11 hours ago |
| MACD: Buy Signal | Nov 2, 10:40 AM | 11 hours ago |
| SMA: Bearish | Nov 2, 9:30 AM | 12 hours ago |
| SMA: Bearish | Nov 2, 9:30 AM | 12 hours ago |
| MACD: Sell Signal | Nov 2, 9:30 AM | 12 hours ago |
| RSI: Oversold | Nov 2, 9:30 AM | 12 hours ago |
| SMA: Bullish | Oct 29, 3:40 PM | 4 days ago |
| SMA: Bearish | Oct 29, 3:30 PM | 4 days ago |
| SMA: Bearish | Oct 29, 2:50 PM | 4 days ago |
| MACD: Buy Signal | Oct 29, 2:10 PM | 4 days ago |
| SMA: Bullish | Oct 29, 2:00 PM | 4 days ago |
| RSI: Oversold | Oct 29, 1:50 PM | 4 days ago |
| RSI: Oversold | Oct 29, 1:00 PM | 4 days ago |
| SMA: Bearish | Oct 29, 12:10 PM | 4 days ago |
| SMA: Bullish | Oct 29, 12:05 PM | 4 days ago |
| SMA: Bearish | Oct 29, 12:00 PM | 4 days ago |
| SMA: Bullish | Oct 29, 11:55 AM | 4 days ago |
| SMA: Bullish | Oct 29, 11:55 AM | 4 days ago |
| MACD: Sell Signal | Oct 29, 11:15 AM | 4 days ago |
| SMA: Bearish | Oct 29, 11:10 AM | 4 days ago |
| SMA: Bearish | Oct 29, 11:05 AM | 4 days ago |
| MACD: Buy Signal | Oct 29, 10:20 AM | 4 days ago |
| SMA: Bullish | Oct 29, 10:15 AM | 4 days ago |
| SMA: Bullish | Oct 29, 10:15 AM | 4 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 28, 3:55 PM | 5 days ago |
| SMA: Bullish | Oct 28, 3:55 PM | 5 days ago |
| SMA: Bearish | Oct 28, 3:50 PM | 5 days ago |
| SMA: Bearish | Oct 28, 3:50 PM | 5 days ago |
| SMA: Bullish | Oct 28, 3:45 PM | 5 days ago |
| SMA: Bullish | Oct 28, 3:45 PM | 5 days ago |
| SMA: Bearish | Oct 28, 3:30 PM | 5 days ago |
| SMA: Bearish | Oct 28, 3:15 PM | 5 days ago |
| MACD: Sell Signal | Oct 28, 3:15 PM | 5 days ago |
| MACD: Buy Signal | Oct 28, 2:40 PM | 5 days ago |
| SMA: Bullish | Oct 28, 2:30 PM | 5 days ago |
| SMA: Bullish | Oct 28, 2:30 PM | 5 days ago |
| SMA: Bearish | Oct 28, 2:25 PM | 5 days ago |
| MACD: Sell Signal | Oct 28, 1:55 PM | 5 days ago |
| MACD: Buy Signal | Oct 28, 1:35 PM | 5 days ago |
| SMA: Bullish | Oct 28, 1:30 PM | 5 days ago |
| SMA: Bullish | Oct 28, 1:30 PM | 5 days ago |
| SMA: Bullish | Oct 28, 1:00 PM | 5 days ago |
| SMA: Bearish | Oct 28, 12:55 PM | 5 days ago |
| SMA: Bullish | Oct 28, 12:35 PM | 5 days ago |
| SMA: Bearish | Oct 28, 11:55 AM | 5 days ago |
| SMA: Bearish | Oct 28, 11:35 AM | 5 days ago |
| SMA: Bearish | Oct 28, 11:20 AM | 5 days ago |
| RSI: Overbought | Oct 28, 11:10 AM | 5 days ago |
| SMA: Bullish | Oct 28, 10:45 AM | 5 days ago |
| MACD: Sell Signal | Oct 28, 10:15 AM | 5 days ago |
| SMA: Bearish | Oct 28, 10:00 AM | 5 days ago |
| RSI: Overbought | Oct 27, 3:40 PM | 6 days ago |
| SMA: Bullish | Oct 27, 3:20 PM | 6 days ago |
| MACD: Buy Signal | Oct 27, 3:20 PM | 6 days ago |
| MACD: Sell Signal | Oct 27, 3:15 PM | 6 days ago |
| SMA: Bullish | Oct 27, 1:40 PM | 6 days ago |
| SMA: Bullish | Oct 27, 1:00 PM | 6 days ago |
| MACD: Buy Signal | Oct 27, 1:00 PM | 6 days ago |
| MACD: Sell Signal | Oct 27, 12:50 PM | 6 days ago |
| SMA: Bearish | Oct 27, 12:25 PM | 6 days ago |
| SMA: Bullish | Oct 27, 12:10 PM | 6 days ago |
| SMA: Bearish | Oct 27, 12:05 PM | 6 days ago |
| SMA: Bullish | Oct 27, 11:50 AM | 6 days ago |
News
10 hours ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Inovio Pharmaceuticals (NASDAQ:INO) shares rose 211.2% to $1.88 during Monday's regular session. The company's market cap stands at $62.2 million. BeyondSpring (NASDAQ:BYSI) stock moved…
4 days ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers iSpecimen (NASDAQ:ISPC) stock moved upwards by 16.1% to $0.92 during Thursday's after-market session. The company's market cap stands at $2.2 million. CareDx (NASDAQ:CDNA) stock rose 15.0% to…
1 week ago businesswire.com
Glucotrack, Inc. Announces Reverse Stock Split
RUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)--Glucotrack Announce Reverse Stock Split.
-
1 month ago benzinga.com
Glucotrack’s Subsidiary Lōkahi Therapeutics Unveils Qare Comparative Health Platform For GLP-1 And Other Treatment Outcomes
Developed Through ai² Accelerator™, Qare™ Is Designed to Enable Users to Compare Their Experiences Against Cohorts of People Like Them, with Additional Drug Classes Expected to FollowLōkahi…
-
1 month ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Firefly Neuroscience (NASDAQ:AIFF) shares increased by 33.2% to $1.58 during Friday's regular session. The company's market cap stands at $18.6 million. Apimeds Pharmaceuticals (AMEX:APUS)…
-
1 month ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Apimeds Pharmaceuticals (AMEX:APUS) shares rose 23.4% to $6.07 during Friday's pre-market session. The market value of their outstanding shares is at $7.4 million. Firefly Neuroscience…
1 month ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Apimeds Pharmaceuticals (AMEX:APUS) shares increased by 162.4% to $6.01 during Thursday's regular session. The market value of their outstanding shares is at $3.4 million. Surrozen…
1 month ago gurufocus.com
Glucotrack, Inc. Announces Pricing of $3 Million Public Offering
Glucotrack, Inc. (NASDAQ: GCTK) (âGlucotrackâ or the âCompanyâ) today announced the pricing of a âbest effortsâ public offering of 169,388 shares of
1 month ago businesswire.com
Glucotrack, Inc. Announces Pricing of $3 Million Public Offering
RUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)--Glucotrack, Inc. Announces Pricing of $3 Million Public Offering.
-
1 month ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Profusa (NASDAQ:PFSA) stock increased by 112.5% to $4.36 during Thursday's pre-market session. The company's market cap stands at $1.2 million. GlucoTrack (NASDAQ:GCTK) stock rose 96.55% to…
1 month ago benzinga.com
Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving Premarket
Shares of GlucoTrack Inc (NASDAQ:GCTK) rose sharply in pre-market trading following the announcement that its subsidiary, Lokahi Therapeutics, signed its first external, fee-for-service partnership.
1 month ago benzinga.com
Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving Premarket
GlucoTrack surged 117.7% premarket after Lokahi Therapeutics signed its first external partnership; other stocks saw notable gains and losses.
1 month ago benzinga.com
Glucotrack Stock Is Trending: Here's Why GCTK Jumped Over 80% After Hours
GlucoTrack shares soar 80% after-hours as Lokahi Therapeutics signs first external glioblastoma licensing partnership with Innovate GBM.
-
1 month ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 90.6% to $3.87 during Wednesday's after-market session. The market value of their outstanding shares is at $1.7 million. Greenland Mines…
-
1 month ago benzinga.com
Glucotrack Subsidiary Lōkahi Therapeutics Engaged Two ai² PIPELINE Project Teams To Identify And Evaluate Brain Tumor Therapeutic Assets Available For Licensing And Development
Innovate GBM becomes the first external organization to engage the ai² Division on a fee-for-service basis to identify brain tumor therapeutic assets for potential licensing and developmentLōkahi…
-
1 month ago benzinga.com
Lōkahi Therapeutics And Glucotrack Issue Update On LT-100 Program And ai² Asset Monetization Strategy
Lōkahi Therapeutics™ today issued a strategic corporate update highlighting progress in its LT-100 development program, expansion of its ai² platform, and priorities for advancing and monetizing…
1 month ago businesswire.com
Lōkahi Therapeutics™ and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai² Platform Growth and Clinical Development Priorities
RUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)--Lōkahi CEO Erik Emerson outlines LT-100 progress, ai² platform growth, and a strategy to discover, advance, and monetize assets.
1 month ago gurufocus.com
Lōkahi Therapeutics™ Continues ai² Pipeline™ Division Collaboration with The University of Alabama to Advance Asset Evaluation and Biopharma Talent
LÅkahi Therapeuticsâ¢, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK), today announced that The University of Alabama's Culverhouse College of Business will
-
1 month ago benzinga.com
Glucotrack’s Lōkahi Therapeutics Announces University Of Alabama’s Culverhouse College Of Business Will Continue Its Participation In ai² Pipeline Division For Upcoming Academic Year
Lōkahi Therapeutics™, a subsidiary of Glucotrack, Inc. (NASDAQ:GCTK), today announced that The University of Alabama’s Culverhouse College of Business will continue its participation in the ai²…
-
1 month ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Biodexa Pharmaceuticals (NASDAQ:BDRX) shares increased by 110.6% to $1.39 during Friday's regular session. Tenon Medical (NASDAQ:TNON) shares rose 69.71% to $8.99. The company's market cap…
1 month ago gurufocus.com
Glucotrack Announces $11.5 Million Financing
Glucotrack, Inc. (NASDAQ: GCTK) (âGlucotrackâ or the âCompanyâ) today announced definitive agreements for convertible notes with an aggregate principal
-
1 month ago benzinga.com
Glucotrack Secures $11.5M Convertible Note Financing
Glucotrack, Inc. (NASDAQ:GCTK) ("Glucotrack" or the "Company") today announced definitive agreements for convertible notes with an aggregate principal amount of approximately $11.5 million, including
1 month ago businesswire.com
Glucotrack Announces $11.5 Million Financing
RUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)-- #Glucotrack--Glucotrack announces $11.5M convertible note financing, including new capital and note rollover, to support strategic growth.
-
1 month ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers iSpecimen (NASDAQ:ISPC) shares increased by 10.4% to $1.7 during Friday's after-market session. The market value of their outstanding shares is at $3.8 million. Genelux (NASDAQ:GNLX) stock…
2 months ago businesswire.com
Glucotrack, Inc. Announces Reverse Stock Split
RUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)--Glucotrack (Nasdaq: GCTK) announced a 1-for-15 reverse stock split effective August 31, 2026, to support Nasdaq listing compliance.
-
2 months ago benzinga.com
Glucotrack's Lōkahi Therapeutic Subsidiary Initiates Good Manufacturing Practice Production Campaign For LT-100
Lōkahi Therapeutics™ Inc., a subsidiary of Glucotrack, Inc. (NASDAQ: GCTK), today announced that it has started its initial Good Manufacturing Practice (GMP) manufacturing campaign for LT-100 (pure…
-
2 months ago benzinga.com
Glucotrack Announces That Nasdaq Hearings Panel Has Granted The Company's Request For Continued Listing, Subject To Conditions
The Panel has confirmed that Glucotrack has regained compliance with Nasdaq's stockholders' equity requirement. The decision represents an important milestone in the Company's efforts to strengthen…
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers INVO Fertility (NASDAQ:IVF) shares increased by 163.4% to $2.56 during Monday's pre-market session. The company's market cap stands at $1.7 million. GlucoTrack (NASDAQ:GCTK) shares moved…
2 months ago businesswire.com
Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation
RUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)--"We are approaching the months ahead with confidence, urgency, and a clear sense of purpose," said Erik Emerson, CEO of Glucotrack.
2 months ago globenewswire.com
E.F. Hutton & Co. Acts as Exclusive Financial Advisor for $5.5 Million Financing for Glucotrack
NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. (“E.F. Hutton”), a leading investment banking and financial advisory firm, today announced that it acted as exclusive financial advisor…
2 months ago businesswire.com
Glucotrack Announces $5.5 Million Financing
RUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)--Glucotrack, Inc. (NASDAQ: GCTK) ("Glucotrack" or the "Company") today announced definitive agreements for approximately $5.5 million in financing…
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Bluejay Diagnostics (NASDAQ:BJDX) stock moved upwards by 42.0% to $1.42 during Tuesday's after-market session. American Well (NYSE:AMWL) stock rose 12.76% to $11.75. The market value of their…
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Replimune Group (NASDAQ:REPL) stock rose 96.1% to $10.61 during Friday's regular session. SCYNEXIS (NASDAQ:SCYX) stock moved upwards by 22.54% to $4.57. The market value of their outstanding…
3 months ago businesswire.com
Lōkahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline
RUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)--Glucotrack (NASDAQ: GCTK) today announced the continued expansion of the ai² Futures Lab™ operated through its wholly owned subsidiary, Lōkahi…
3 months ago benzinga.com
Why Amazon Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Amazon reported strong Q2 results, beating revenue and earnings estimates. Shares jumped 11.9% in pre-market trading while other stocks also saw gains/losses.
3 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Nuwellis (NASDAQ:NUWE) stock moved upwards by 123.7% to $4.23 during Thursday's regular session. GlucoTrack (NASDAQ:GCTK) shares moved upwards by 79.85% to $0.51. The company's market cap…
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Nuwellis (NASDAQ:NUWE) stock rose 119.0% to $4.14 during Thursday's pre-market session. GlucoTrack (NASDAQ:GCTK) stock increased by 47.36% to $0.42. The market value of their outstanding…
3 months ago benzinga.com
Why Microsoft Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket
Microsoft (NASDAQ: MSFT) reported strong Q4 results, beating revenue and earnings estimates. Shares jumped 7.8% in pre-market trading.
3 months ago benzinga.com
GlucoTrack (GCTK) Stock Surges Over 70% After Hours: Why is it Moving?
GlucoTrack shares surged 70.25% after hours as investors reacted to its simplified single-injection strategy for LT-100 development.
-
3 months ago benzinga.com
GlucoTrack's Subsidiary, Lōkahi Therapeutics, Advances LT-100 Development Strategy Toward Single-Injection Administration; FDA Type C Meeting and Nonclinical Study Advance Strategy To Transition LT-100 From 15 Injections To One
Lōkahi Therapeutics™ Inc., a wholly owned subsidiary of Glucotrack, Inc. (NASDAQ:GCTK), today announced progress in its LT-100 development strategy focused on evaluating whether a historical…
3 months ago businesswire.com
Lōkahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration
RUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)--Lōkahi Therapeutics™ Inc., a wholly owned subsidiary of Glucotrack, Inc. (NASDAQ: GCTK), today announced progress in its LT-100 development…
-
3 months ago benzinga.com
Glucotrack Has Been Granted U.S. Patent Number 12,129,085 Titled "Methods and systems for continuously monitoring the glucose level of a patient".
https://ppubs.uspto.gov/pubwebapp/external.html?q=(12690787).pnhttps://x.com/PatentGrants/status/2082194682885587390
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers China Pharma Holding (AMEX:CPHI) shares increased by 713.2% to $7.4 during Tuesday's regular session. The company's market cap stands at $36.8 million. Wellgistics Health (NASDAQ:WGRX) shares…
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Jupiter Neurosciences (NASDAQ:JUNS) stock rose 36.4% to $0.23 during Tuesday's pre-market session. The market value of their outstanding shares is at $7.9 million. Imunon (NASDAQ:IMNN) shares…
3 months ago benzinga.com
Why Crown Holdings Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Crown Holdings Inc (CCK) stock gained 16.4% in pre-market trading after reporting strong Q2 results and raising its FY26 EPS guidance. Other gaining stocks include SLGB, HIHO, WNW, CHNR, RDGT, ULBI,…
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 25.1% to $3.79 during Monday's after-market session. The company's market cap stands at $1.8 million. China Pharma Holding…
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Zhengye Biotechnology (NASDAQ:ZYBT) shares increased by 322.6% to $2.95 during Monday's regular session. The company's market cap stands at $33.0 million. Advanced Biomed (NASDAQ:ADVB) stock…
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Advanced Biomed (NASDAQ:ADVB) shares rose 24.1% to $6.24 during Monday's pre-market session. The market value of their outstanding shares is at $8.2 million. Barinthus Biotherapeutics…
3 months ago benzinga.com
Why Eva Live Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Eva Live gained 16.4% in pre-market trading after signing a letter of intent to acquire Airbeam Wireless Technologies for $16 million.
3 months ago globenewswire.com
E.F. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Convertible Note Financing
NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. (“E.F. Hutton”), a leading investment banking and financial advisory firm, today announced that it served as exclusive financial advisor…